13 min
Kummar on the Investigation of Rezatapopt in TP53 Y220C–Mutated Advanced Solid Tumors OncLive® On Air
-
- Health & Fitness
Dr Kummar discusses the significance of targeting TP53 Y220C in solid tumors and early data reported with rezatapopt in TP53 Y220C–mutant solid tumors.
Dr Kummar discusses the significance of targeting TP53 Y220C in solid tumors and early data reported with rezatapopt in TP53 Y220C–mutant solid tumors.
13 min